April 15 (Reuters) - Neumora Therapeutics ( NMRA ) said
on Monday the U.S. Food and Drug Administration had placed a
clinical hold on early-stage study of its experimental
schizophrenia drug.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini
Ganguli)